Quick Answer
Serina Therapeutics, Inc. reported Total Assets of $6.95 million for fiscal year 2025.
Serina Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $6.95M | +3.4% |
| 2024 | $6.72M | -25.0% |
| 2023 | $8.97M | +176.7% |
| 2022 | $3.24M | +2.8% |
| 2021 | $3.15M | -19.6% |
| 2020 | $3.92M | -47.3% |
| 2019 | $7.44M | -30.3% |
| 2018 | $10.67M | +10.8% |
| 2017 | $9.63M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $12.41M | +67.0% | +38.8% |
| June 30, 2025 | $8.94M | -16.5% | +32.8% |
| March 31, 2025 | $6.73M | -38.0% | +0.1% |
| December 31, 2024 | $6.72M | -25.0% | -9.6% |
| September 30, 2024 | $7.43M | -39.1% | -30.6% |
| June 30, 2024 | $10.71M | -12.8% | -1.4% |
| March 31, 2024 | $10.86M | -13.4% | +21.1% |
| December 31, 2023 | $8.97M | +176.7% | -26.6% |
- Serina Therapeutics, Inc. showed an increase of +3.4% in Total Assets compared to the prior fiscal year.
- Over the 2017–2025 period, Serina Therapeutics, Inc.’s total assets has declined by 27.8% (from $9.63 million to $6.95 million).
- The most recent figure is from Serina Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: